Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Supply Agreement

6 Dec 2006 07:03

Aortech International PLC06 December 2006 6 December 2006 AorTech International plc AorTech International plc announces exclusive material supply agreement with Harland Medical Systems, LLC London, UK - AorTech International plc (AIM: AOR), the medical devicedevelopment and biomaterials intellectual property and licensing company, todayannounces the signing of an exclusive material licensing and supply agreementwith Harland Medical Systems, LLC of Eden Prairie, Minnesota. Harland Medical Systems is a leading supplier of coating technology and servicesfor the medical device industry. The license agreement is exclusive in the fieldof short-term guide wire and catheter coating applications and containsprovisions for an up-front payment, material supply and royalties. The licensealso permits Harland the use of the Elast-EonTM trademark. Terms of the agreement were not released. Frank Maguire, AorTech CEO said, "The relationship with Harland Medical Systemsbegan as an offshoot to coating work they were providing for existing AorTechcustomers. During the course of the past year, we have been impressed with theircapabilities and the relationships they have within the medical device industry.This license for short term applications permits AorTech to exploit a range ofopportunities with a capable partner that we would otherwise find difficult toaccess. Jon Anderson, Harland Medical Systems CEO said, "We look forward to building onour relationship with AorTech as we put their advanced biomaterials to work in avariety of exciting new medical device applications. We have been veryencouraged with the technology and quality of the AorTech materials along withthe skill of AorTech's management and technical team." -Ends-Enquiries: AorTech International plc Tel: + 1 801 581 0854Frank Maguire, Chief Executive OfficerHogarth Partnership Ltd Tel: + 44 (0)20 7357 9477Andrew Jaques/Sarah RichardsonHarland Medical Systems, LLC Tel: + 1 952 941 0475Jon Anderson, Chief Executive Officer About AorTech International plc Listed on AIM in London, AorTech International plc wholly owns AorTechBiomaterials Pty Ltd based in Melbourne, Australia. AorTech Biomaterials wasformed in July 1997 to commercialise a range of medical grade polyurethanes formedical implants developed by the Commonwealth Scientific and IndustrialResearch Organisation (CSIRO). AorTech's Elast-EonTM technology is the product of a decade of fundamentalresearch into biologically stable materials. Elast-EonTM materials are patented,high silicone content, polyurethane copolymers which exhibit unparalleledbiological and mechanical performance. AorTech is firmly focused on the development and refinement of this material forthe medical community, with the aim of providing a wide range of highperformance Elast-EonTM materials in a variety of application specificformulations and densities, for use in medical devices. About Harland Medical Systems Harland Medical Systems, LLC based in Eden Prairie, Minnesota is committed toenabling the wide scale adoption of advanced biomaterials and surfacemodification chemistries and processes within the medical device community. Harland Medical Systems works with medical device manufacturers from earlyproduct development through volume production to ensure that all of the coatingrelated aspects of their medical device program are successfully implemented,including materials and chemistry selection, feasibility and bridge coating,coating automation and test systems, assistance with quality and regulatoryissues, and implementation of long term manufacturing plans. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Dec 20178:58 amRNSHolding(s) in Company
12th Dec 20178:30 amRNSHolding(s) in Company
11th Dec 20179:08 amRNSInterim Results
11th Dec 20177:51 amRNSSettlement of Litigation
8th Dec 20174:08 pmRNSCORRECTION: Holdings in Company
20th Nov 20177:01 amRNSResponse to Media Comment
20th Nov 20177:00 amRNSChange of Adviser
29th Sep 20178:17 amRNSResult of AGM
14th Sep 20177:00 amRNSHolding(s) in Company
8th Sep 20173:48 pmRNSHolding(s) in Company
31st Aug 20171:05 pmRNSNotice of AGM and Posting of Accounts
18th Aug 20175:24 pmRNSHolding(s) in Company
18th Aug 20173:10 pmRNSHolding(s) in Company
16th Aug 20177:00 amRNSFinal Results
13th Jul 20174:49 pmRNSHolding(s) in Company
27th Mar 20178:28 amRNSHolding(s) in Company
13th Mar 20177:00 amRNSHolding(s) in Company
18th Jan 20177:00 amRNSHolding(s) in Company
6th Jan 20173:12 pmRNSHolding(s) in Company
21st Dec 20167:00 amRNSInterim Results
14th Oct 20163:41 pmRNSBoard Change
27th Sep 20165:09 pmRNSResult of AGM
21st Sep 20165:28 pmRNSHolding(s) in Company
15th Aug 20167:00 amRNSFinal Results
29th Jul 20162:58 pmRNSChange of Website
10th Jun 20165:46 pmRNSHolding(s) in Company
31st May 20168:39 amRNSHolding(s) in Company
9th May 20169:15 amRNSHolding(s) in Company
22nd Apr 20164:45 pmRNSHolding(s) in Company
29th Dec 201512:55 pmRNSHolding(s) in Company
23rd Dec 20153:52 pmRNSHolding(s) in Company
21st Dec 20152:57 pmRNSResult of General Meeting of Loan Note Holders
2nd Dec 20157:00 amRNSConversion of loan notes update
27th Nov 20157:33 amRNSInterim Results
24th Sep 201512:05 pmRNSResult of AGM and Share Capital Reorganisation
1st Sep 20158:13 amRNSNotice of AGM and Posting of Accounts
10th Aug 20155:37 pmRNSHolding(s) in Company
7th Aug 20157:00 amRNSFinal Results
28th May 20158:40 amRNSBoard Change
15th May 20152:56 pmRNSHolding(s) in Company
16th Apr 20157:00 amRNSUpdate
27th Nov 20147:00 amRNSInterim Results
30th Sep 201411:48 amRNSResult of AGM
18th Aug 20147:00 amRNSPreliminary results for the year to 31 March 2014
16th Jun 20147:00 amRNSTrading and Commercial Update
13th Dec 20139:00 amRNSUnaudited interim results to 30 September 2013
3rd Dec 20137:00 amRNSBoard Reorganisation
4th Nov 20137:00 amRNSHolding(s) in Company
17th Oct 20133:45 pmRNSHolding(s) in Company
11th Oct 20134:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.